Bromodomain Tc BDF2 inhibitor

N/A

Report date: 2025/03/19 11:43:18
NME

Base Information

Drug NameBromodomain Tc BDF2 inhibitor
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsChagas Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsChagas Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A